Senti Biosciences Inc

NAS:SNTI (USA)  
$ 4.17 +0.17 (+4.25%) 11:09 PM EST
At Loss
P/B:
1.20
Market Cap:
$ 19.14M
Enterprise V:
$ 43.37M
Volume:
59.06K
Avg Vol (2M):
3.34M
Trade In:
Volume:
59.06K
At Loss
Avg Vol (2M):
3.34M

Business Description

Description
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Name Current Vs Industry Vs History
Cash-To-Debt 0.3
Equity-to-Asset 0.28
Debt-to-Equity 2.17
Debt-to-EBITDA -0.61
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.68
9-Day RSI 44.66
14-Day RSI 48.94
6-1 Month Momentum % -13.87
12-1 Month Momentum % -58.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.92
Quick Ratio 1.92
Cash Ratio 1.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.5
Shareholder Yield % 7.7
Name Current Vs Industry Vs History
FCF Margin % -1766.89
ROE % -133.22
ROA % -71.17
ROIC % -87.62
ROC (Joel Greenblatt) % -132.02
ROCE % -70.37

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 9.35
PB Ratio 1.2
Price-to-Tangible-Book 1.19
EV-to-EBIT -0.68
EV-to-EBITDA -0.75
EV-to-Revenue 21.53
EV-to-FCF -1.22
Earnings Yield (Greenblatt) % -147.06
FCF Yield % -182.63

Financials (Next Earnings Date:2025-03-21 Est.)

SNTI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SNTI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Senti Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.978
EPS (TTM) ($) -15.54
Beta 0
Volatility % 73.47
14-Day RSI 48.94
14-Day ATR ($) 0.921978
20-Day SMA ($) 5.0515
12-1 Month Momentum % -58.26
52-Week Range ($) 1.5201 - 16.94
Shares Outstanding (Mil) 4.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Senti Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Senti Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Senti Biosciences Inc Frequently Asked Questions

What is Senti Biosciences Inc(SNTI)'s stock price today?
The current price of SNTI is $4.17. The 52 week high of SNTI is $16.94 and 52 week low is $1.52.
When is next earnings date of Senti Biosciences Inc(SNTI)?
The next earnings date of Senti Biosciences Inc(SNTI) is 2025-03-21 Est..
Does Senti Biosciences Inc(SNTI) pay dividends? If so, how much?
Senti Biosciences Inc(SNTI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1